Product Images Pregabalin

This is a formula for estimating creatinine clearance in patients. The formula involves multiplying the age in years by the weight in kilograms and then dividing by the serum creatinine level in mg/dL. For female patients, the result is further multiplied by 0.85. The calculation is commonly used in clinical settings to assess kidney function.*

This text provides information on the percentage of patients improved using Progabalin at different doses (100mg and 50mg three times a day). It also includes a graph showing the percentage improvement in pain from baseline.*

This text provides information on the percentage of patients improved with different daily doses of Progabalin. The chart shows the improvement scale and the corresponding dose levels for Progabalin. It also includes a graph illustrating the improvement in patients from the baseline over time.*

The text shows data related to subjects and their improvement percentages. Subjects' baselines and improvements from week 1 to week 1280CF are provided. The percentages indicate the level of improvement for each subject over time.*

This is a medication description for Pregabalin capsules, each containing 25 mg of the active ingredient. The manufacturer is V-Ensure Pharma Technologies Pvt. Ltd. located in Raigad, Maharashtra, India. The usual dosage information should be referred to from the accompanying prescribing information. The product is distributed by Creekwood Pharmaceuticals LLC. It should be stored between 20°C to 25°C (68°F to 77°F) and dispensed in tight, child-resistant containers. Each package contains 90 capsules and has an expiration date of 08/2024. Manufacturing license number: MH/104129.*

This information provides details about a medication capsule with the NDC code 82619-123-01 containing Pregabalin USP 50 mg. The manufacturer is V-Ensure Pharma Technologies Pvt. Ltd located in Raigad, Maharashtra, India. The usual dosage information and storage instructions are included in the text. The capsules should be stored at a temperature between 20° to 25°C (68° to 77°F). The distributor is Creekwood Pharmaceuticals LLC based in Parsippany, NJ. The prescription is for 90 capsules and includes an expiration date of 08/2024. The medication guide must always be dispensed with the product. Additionally, the manufacturer's license number is MH/104129.*

This text provides information on a medication called Pregabalin, with a dosage of 75 mg per capsule. The manufacturer is V-Ensure Pharma Technologies Pvt. Ltd in Raigad, Maharashtra, India. The distributor is Creekwood Pharmaceuticals LLC in Parsippany, NJ. It is advised to store the capsules at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The product comes in a container that is both tight and child-resistant. It is important to always dispense the medication with the medication guide provided. The package includes 90 capsules and the expiration date is August 2024. Manufacturing license number MH/104129 is also mentioned.*

This is information related to a medication with the NDC code 82619-125-01 which contains 100mg of Pregabalin USP per capsule. The manufacturer is V-Ensure Pharma Technologies Pvt. Ltd in Raigad, Maharashtra, India. The usual dosage information should be found in the accompanying prescribing information. The capsules should be stored at 20° to 25°C (68° to 77°F) and dispensed in tight, child-resistant containers. It is important to dispense this medication with a medication guide. This particular package contains 90 capsules and the expiration date is in August 2024. The manufacturing license number is MH/104129.*

This is a description of a medication containing Pregabalin USP 150 mg in capsule form. The capsules are manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in Raigad, Maharashtra, India. The usual dosage information can be found in the accompanying prescribing information. The medication is distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ. It is recommended to store the capsules at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). The medication should be dispensed in tight, child-resistant containers and always dispensed with a medication guide. The issue date for this information is 08/2024. It is for prescription use only, with 90 capsules provided in each package. Manufacturing License Number is MH/104129, and the code LA1260101 is referenced.*

The text provides information about a drug named Pregabalin USP 200 mg in capsule form. It includes details of the manufacturer, V-Ensure Pharma Technologies Pvt. Ltd., located in Raigad, Maharashtra, India, and the distributor, Creekwood Pharmaceuticals LLC, based in Parsippany, NJ. The recommended storage conditions are between 20°C to 25°C (68°F to 77°F), with excursions permitted up to 30°C (86°F). The capsules should be dispensed in tight, child-resistant containers. The prescription is for 90 capsules, and the issue date is in August 2024. Please note the text also mentions the importance of dispensing medication with a guide.*

This text provides information about a medication containing Pregabalin USP 225 mg in each capsule. It is manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in Raigad, Maharashtra, India. The usual dosage and additional prescribing information is available from Creekwood Pharmaceuticals LLC. The capsules should be stored at 20° to 25°C, with excursions permitted to 15° to 30°C. It is advised to dispense in tight (USP), child-resistant containers. The medication should always be dispensed with a medication guide. The expiration date indicated is 08/2024, and the package contains 90 capsules. Manufacturing license number is MH/104129.*

This text provides details about medication capsules containing a specified issue date, NDC number, and manufacturing license number. Instructions on storage conditions, dosage guidance, and dispensing information are included. The capsules should be kept at 20-25°C (68-77°F) with some temperature variations allowed. The manufacturer and distributor information is also given. It is recommended to dispense the capsules in tight, child-resistant containers, and always with a medication guide.*